Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP989512.RA4JcusEfq72UjNTx5_O0BBxXrY8O1vUyRcQ8heuALJyM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP989512.RA4JcusEfq72UjNTx5_O0BBxXrY8O1vUyRcQ8heuALJyM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP989512.RA4JcusEfq72UjNTx5_O0BBxXrY8O1vUyRcQ8heuALJyM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP989512.RA4JcusEfq72UjNTx5_O0BBxXrY8O1vUyRcQ8heuALJyM130_provenance.
- NP989512.RA4JcusEfq72UjNTx5_O0BBxXrY8O1vUyRcQ8heuALJyM130_assertion description "[Alpha-2-macroglobulin (alpha-2M; encoded by the gene A2M) is a serum pan-protease inhibitor that has been implicated in Alzheimer disease (AD) based on its ability to mediate the clearance and degradation of A beta, the major component of beta-amyloid deposits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP989512.RA4JcusEfq72UjNTx5_O0BBxXrY8O1vUyRcQ8heuALJyM130_provenance.
- NP989512.RA4JcusEfq72UjNTx5_O0BBxXrY8O1vUyRcQ8heuALJyM130_assertion evidence source_evidence_literature NP989512.RA4JcusEfq72UjNTx5_O0BBxXrY8O1vUyRcQ8heuALJyM130_provenance.
- NP989512.RA4JcusEfq72UjNTx5_O0BBxXrY8O1vUyRcQ8heuALJyM130_assertion SIO_000772 9697696 NP989512.RA4JcusEfq72UjNTx5_O0BBxXrY8O1vUyRcQ8heuALJyM130_provenance.
- NP989512.RA4JcusEfq72UjNTx5_O0BBxXrY8O1vUyRcQ8heuALJyM130_assertion wasDerivedFrom befree-20150227 NP989512.RA4JcusEfq72UjNTx5_O0BBxXrY8O1vUyRcQ8heuALJyM130_provenance.
- NP989512.RA4JcusEfq72UjNTx5_O0BBxXrY8O1vUyRcQ8heuALJyM130_assertion wasGeneratedBy ECO_0000203 NP989512.RA4JcusEfq72UjNTx5_O0BBxXrY8O1vUyRcQ8heuALJyM130_provenance.
- befree-20150227 importedOn "2015-02-27" NP989512.RA4JcusEfq72UjNTx5_O0BBxXrY8O1vUyRcQ8heuALJyM130_provenance.